Figure 1. Kaplan-Meier survival analysis by PCLI response. Median overall survival was significantly longer in PCLI responders (54 months, 95% CI 45-297; P = .02) versus 29 months (95% CI 22-44) in nonresponders (P = .02).
Figure 1

Kaplan-Meier survival analysis by PCLI response. Median overall survival was significantly longer in PCLI responders (54 months, 95% CI 45-297; P = .02) versus 29 months (95% CI 22-44) in nonresponders (P = .02).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal